Literature DB >> 24654773

Variant alleles of VEGF and risk of esophageal cancer and lymph node metastasis.

Haiyong Gu1, Wanshan Qiu, Yijun Shi, Suocheng Chen, Jun Yin.   

Abstract

CONDENSED ABSTRACT: The variant alleles of the functional polymorphisms, VEGF -2578 C > A, -1498 T > C and +936 C > T, were not associated with risk of esophageal cancer and lymph node metastasis. Compared with the most common haplotype, C-2578T-1498C+936, the A-2578C-1498C+936 haplotype was associated with a borderline significantly increased risk of esophageal cancer. C-2578C-1498C+936 and A-2578T-1498T+936 haplotypes were associated with significantly increased risk of esophageal cancer. Vascular endothelial growth factor (VEGF) is a potent stimulator for angiogenesis. It has been implicated in the growth and metastasis of esophageal cancer. Three functional single nucleotide polymorphisms (SNPs) of VEGF (-2578 C > A, -1498 T > C and +936 C > T) are known to be related to VEGF expression. We conducted a case-control study to evaluate the effects of these three functional SNPs on the development of esophageal cancer and lymph node metastasis. A total of 497 cases and 380 controls were analyzed. Genotypes were determined by matrix assisted laser desorption/ionization time-of-flight mass spectrometry and direct sequence methods. The variant alleles of the functional polymorphisms VEGF -2578 C > A, -1498 T > C and +936 C > T SNPs were not associated with esophageal cancer risk. These VEGF genotypes were not associated with the risk of esophageal cancer after stratification. Furthermore, no association was observed between VEGF -2578 C > A, -1498 T > C and +936 C > T polymorphisms and lymph node metastasis. Compared with the most common haplotype C-2578T-1498C+936, the A-2578C-1498C+936 haplotype was associated with a borderline significantly increased risk of esophageal cancer. C-2578C-1498C+936 and A-2578T-1498T+936 haplotypes were associated with significantly increased risk of esophageal cancer. Variants in the functional polymorphisms of VEGF may not contribute to esophageal cancer and lymph node metastasis susceptibility. VEGF A-2578C-1498C+936, C-2578C-1498C+936 and A-2578T-1498T+936 haplotypes may be associated with increased risk of esophageal cancer. However, our results were obtained with a limited sample size and therefore this is a preliminary conclusion. Validation by a larger study with more diverse ethnic populations is needed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24654773     DOI: 10.3109/1354750X.2014.902997

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  4 in total

Review 1.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

2.  Impact of VEGFA promoter polymorphisms on esophageal cancer risk in North-West Indians: a case-control study.

Authors:  Kamlesh Guleria; Simranjot Kaur; Deepanshi Mahajan; Vasudha Sambyal; Meena Sudan; Manjit Singh Uppal
Journal:  Genes Genomics       Date:  2022-06-29       Impact factor: 2.164

3.  Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway.

Authors:  Yang Xia; Peng Wang; Yunyao Ye; Sihui Zhang; Guangzhi Sun; Jie Xu; Gaohua Han
Journal:  Biomed Res Int       Date:  2022-04-15       Impact factor: 3.246

4.  SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.

Authors:  Guiqin Song; Kang Liu; Xiaolin Yang; Bo Mu; Junbao Yang; Lang He; Xin Hu; Qiujiang Li; Yunxia Zhao; Xiaoming Cai; Gang Feng
Journal:  Oncotarget       Date:  2017-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.